XML 26 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727
Warrants and Options
6 Months Ended
Jun. 30, 2015
Temporary Equity Disclosure [Abstract]  
Warrants and Options

9. Warrants and options

 

Warrants:

During the fiscal year ended December 31, 2014, the Company granted 4,200,000 warrants to purchase shares of Common Stock which all have a 1 year exercise term, of which 3,100,000 remain outstanding at March 31, 2015. During the quarter ended June 30, 2015, 1,300,000 warrants were issued. The Company valued all warrants utilizing a Black-Scholes option pricing model and the fair value was recorded in additional paid-in capital.

The following is a summary of the Company’s warrant activity:

   

 

 

Warrants

  Weighted Average Exercise Price
Exercisable – December 31, 2013     4,358,000   $           1.50
Granted-2014   4,200,000                1.50
Exercised-2014   -   -
Forfeited-2014   (4,358,000)   -
Outstanding – December 31, 2014   4,200,000   $           1.50
Exercisable – December 31, 2014   4,200,000   $           1.50
         
   

 

 

Warrants

  Weighted Average Exercise Price
Granted-2015 (at June 30, 2015)   1,950,000   $           1.50
Exercised-2015 (at June 30,2015)   -   -
Forfeited-2015 (at June 30, 2015)   (2,200,000)   $           1.50
Outstanding – June 30, 2015   3,950,000   $           1.50
Exercisable – June 30, 2015   3,950,000   $           1.50

 

 

 

 

 

 

Warrants outstanding and exercisable at June 30, 2015 are as follows:

 

Warrants Outstanding   Warrants Exercisable
 

Range of

Exercise Price

 

Number

Outstanding

 

Weighted Average

Remaining Contractual

Life (in Years)

 

Weighted Average

Exercise Price

   

Number

Exercisable

   

Weighted Average

Exercise Price

 
$ 1.50   500,000   0.06 years   $ 1.50       500,000     $ 1.50  
$ 1.50   250,000   0.15 years   $ 1.50       250,000     $ 1.50  
$ 1.50   150,000   0.21 years   $ 1.50       150,000     $ 1.50  
$ 1.50   100,000   0.25 years   $ 1.50       100,000     $ 1.50  
$ 1.50   100,000   0.29 years   $ 1.50       100,000     $ 1.50  
$ 1.50   80,000   0.36 years   $ 1.50       80,000     $ 1.50  
$ 1.50   70,000   0.41 years   $ 1.50       70,000     $ 1.50  
$ 1.50   250,000   0.42 years   $ 1.50       250,000     $ 1.50  

 

$

1.50   250,000   0.46 years   $ 1.50       250,000     $ 1.50  
$ 1.50   250,000   0.50 years   $ 1.50       250,000     $ 1.50  
$ 1.50   250,000   0.53 years   $ 1.50       250,000     $ 1.50  
$ 1.50   150,000   0.66 years   $ 1.50       150,000     $ 1.50  
$ 1.50   100,000   0.70 years   $ 1.50       100,000     $ 1.50  
$ 1.50   150,000   0.75 years   $ 1.50       150,000     $ 1.50  
$ 1.50   50,000   0.79 years   $ 1.50       50,000     $ 1.50  
$ 1.50   150,000   0.81 years   $ 1.50       150,000     $ 1.50  
$ 1.50   100,000   0.84 years   $ 1.50       100,000     $ 1.50  
$ 1.50   500,000   0.91 years   $ 1.50       500,000     $ 1.50  
$ 1.50   500,000   0.92 years   $ 1.50       500,000     $ 1.50  

 

Warrant activity is as follows:

Effective July 23 2014, 500,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective August 29 2014, 250,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective September 29, 20144, 150,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective September 30, 2013, 100,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective October 15 2014, 100,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective November 7, 2014, 80,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective November 28, 2014, 70,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective December 4, 2014, 250,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective December 15, 2014, 250,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective January 3, 2015, 250,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective January 23, 2015, 250,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective January 30, 2015, 150,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective March 15, 2015, 100,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective March 31, 2015, 150,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective April 16, 2015, 50,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective April 23, 2015, 150,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective May 4, 2015, 100,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective May 28, 2015, 500,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Effective June 1, 2015, 500,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and the warrants expire in 1 year

Stock Options:

 

During the period that the options were issued, the Company had no public trading activity for the Company’s common stock. However, the Company sold in private transactions shares at $1.00 per share. In order to value the Company’s options, the Company chose to use the minimum value method, even though the Company is a public company since there was no measurable trading activity. The fair value of the options was recorded in additional paid-in capital.

 

Options outstanding and exercisable at June 30, 2015 are as follows:

 

   

 

 

Options

 

Weighted

Average Exercise Price

Outstanding – December 31, 2013        305,000   $ 0.836
Exercisable – December 31, 2013        105,000   $ 0.524
Granted-2014   -   $ -
Exercised-2014   -   -
Forfeited-2014   -   -
Outstanding – December 31, 2014   305,000   $ 0.836
Exercisable – December 31, 2014   155,000   $ 0.678
   

 

 

Options

  Weighted Average Exercise Price
Granted-2015 (at June 30, 2015)   160,000   $ -
Exercised-2014 (at March 31, 2015)   -   -
Forfeited-2014 (at March 31, 2015)   -   $ -
Outstanding – June 30, 2015   465,000   $ 0.893

Exercisable – June 30, 2015

 

  315,000   $ 0.840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding and exercisable at June 30, 2015 are as follows:

 

Options Outstanding   Options Exercisable  
 

Range of

Exercise Price

 

Number

Outstanding

 

Weighted Average

Remaining Contractual

Life (in Years)

 

Weighted Average

Exercise Price

   

Number

Exercisable

   

Weighted Average

Exercise Price

 
$ 0.001   50,000    .35 years   $ 0.001       50,000            $ 0.001  
$ 1.000   35,000   2.59 years   $ 1.000       35,000            $ 1.000
$ 1.000   10,000   2.67 years   $ 1.000       10,000            $ 1.000
$ 1.000   200,000   8.42 years   $ 1.000       50,000            $ 1.000
$ 1.00   10,000   3.49 years   $ 1.000       10,000            $ 1.000
$ 1.00   50,000   9.51 years   $ 1.000       50,000            $ 1.000
$ 1.00   10,000   9.58 years   $ 1.000       10,000            $ 1.000
$ 1.00   100,000   9.84 years   $ 1.000       100,000            $ 1.000
                                                 

 

 

 

 

 

 

Stock option activity is as follows:

Effective November 2, 2010 the Board of Directors of the Company granted 50,000 non-statutory stock options to a former consultant at an exercise price of $.001 per share with the vesting date of November 2, 2013 and an expiration date of November 2, 2016.

Effective February 1, 2013 the Board of Directors of the Company granted 20,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of February 1, 2013 and an expiration date of February 1, 2018.

 

Effective February 1, 2013 the Board of Directors of the Company granted 5,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018.

 

Effective February 1, 2013 the Board of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018.

 

Effective March 1, 2013 the Board of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of March 1, 2013 and an expiration date of March 1, 2018.

 

Effective December 27, 2013 the Board of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of December 27, 2013 and an expiration date of December 27, 2018.

 

Effective January 1, 2015 the Board of Directors of the Company granted 50,000 non-statutory incentive stock options to a current employee at an exercise price of $1.00 per share with 25% of the shares vested on January 1, 2016 and an additional 25% of shares exercisable on each of the next succeeding three anniversaries of January 1, with the full portion exercisable on and after January 1, 2019. These shares have an expiration date of January 1, 2025.

 

Effective January 23, 2015 the Board of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of January 23, 2015 and an expiration date of January 23, 2025.

 

Effective April 30, 2015 the Board of Directors of the Company granted 100,000 non-qualified stock options to a current consultant at an exercise price of $1.00 per share with the vesting date of April 30, 2015 and an expiration date of April 30, 2025